GIP also does these things, although less effectively than GLP-1
This helps to minimise side effects while ensuring you can safely maintain your weight loss during the switch
Some people experience noticeable drowsiness while taking Mounjaro, and you should speak with your healthcare provider about persistent or severe sleepiness
PIO, GLP-1R agonists, SGLT2 inhibitors and NAFLD: pathophysiological background PIO PIO, currently the only thiazolidinedione (TZD) in clinical practice, is a potent exogenous agonist of the nuclear peroxisome proliferator-activated receptor-gamma (PPAR-) and to a lesser extent, PPAR- [17, 44]
SEMA was recently suggested to be the most effective of its category in terms of weight loss
We are grateful to our participants for taking part in the trial